A carregar...
Current development of chimeric antigen receptor T-cell therapy
Chimeric antigen receptor (CAR) T-cell therapy has achieved great success in recent years, with encouraging complete remission rate and long-term durability of response, especially in advanced B-cell malignancies. With the approval of tisagenlecleucel and axi-cel by FDA to treat refractory/relapsed...
Na minha lista:
| Publicado no: | Stem Cell Investig |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327156/ https://ncbi.nlm.nih.gov/pubmed/30701179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/sci.2018.11.05 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|